NCT07365943Completed
The Effect of Forgiveness-based Motivational Interviewing
The Effect of Forgiveness-based Motivational Interviewing on Death Anxiety, Life Satisfaction, and Forgiveness Disposition in Patients With COPD: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 26 Jan 2026
Brief summary (registry, in English)
This study aimed to examine the effect of forgiveness-based motivational interviewing on death anxiety, life satisfaction, and forgiveness disposition in patients with COPD. A randomized controlled experimental design with pretest, posttest, and one-month follow-up measurements was employed. The study sample consisted of 30 patients (experimental group: 15; control group: 15). The experimental group received forgiveness-based motivational interviewing, whereas no intervention was provided to the control group. Data were collected using a personal information form, the Death Anxiety Scale, the Life Satisfaction Scale, and the Forgiveness Scale. The findings revealed that, in the posttest and follow-up measurements, the experimental group had significantly lower mean scores on the Death Anxiety Scale compared to the control group (p\<0.05). Furthermore, the experimental group demonstrated significantly higher mean scores on the Life Satisfaction Scale and the Forgiveness Scale in the posttest and follow-up measurements than the control group (p\<0.05). This study concluded that forgiveness-based motivational interviewing effectively reduces death anxiety while enhancing life satisfaction and forgiveness disposition in patients with COPD. Therefore, implementing motivational interviewing for patients is recommended.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 17 Jan 2026
- Start date
- 1 Jun 2024
- Primary completion date
- 27 Sept 2024
- Lead sponsor
- Ömer USLU
- Diseases
- COPD
- NCT number
- NCT07365943
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From 1 Jun 2024 to the primary completion date, 27 Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Determined having communication barriers due to disease symptoms,
- Having a chronic psychiatric disorder that would interfere with participation in the study.
Other
- Experiencing dyspnea at a level that prevents cooperation
Who the study is looking for
- They must be 18 years of age or older,
- Possess sufficient mental capacity and communication skills to follow the study guidelines, be literate,
- Have a diagnosis of COPD,
- Have been hospitalized in the pulmonary diseases unit between June and September 2024.
Age in the registry: 18 years to 75 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bergama Necla Mithat Öztüre State Hospital Coordinator of this site? Confirm its status | Izmir | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.